| |
|
|
|
KemPharm- Inc.  
|
|
4.4 -0.15 (-0.03%) |
08-15 16:00 |
|
Open: |
4.6 |
Pre close: |
4.55 |
Target:
|
5.82
|
|
High: |
4.6 |
Low: |
4.35 |
Resistance:
|
4.99
5.75
|
|
Volume: |
28,544 |
Market Cap: |
69M |
Support:
|
3.75
3.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.63
 |
MACD |
MACD(12,26):
|
-0.21  |
|
MA(20): |
4.43 |
Signal(12,26,9): |
-0.30 |
|
MA(100): |
5.79 |
Stochastic Oscillator |
%K(14,3):
|
59.65 |
|
MA(250): |
5.01 |
%D(3): |
67.86 |
|
Average Volume(K) |
3-Month: |
15770
|
52-Week |
High:
|
8.40 |
|
10-Days: |
8899 |
Low: |
2.50 |
|
RSI |
RSI(14):
|
40.48 |
Change(%): |
54.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.420 |
Return on Equity (ttm) |
93.8 |
Shares Out. (M) |
15.76 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-90.1 |
Shares Float (M) |
15.48 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.80 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
32.80 |
|
Forward EPS |
-2.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1248 |
|
Book Value (p.s.) |
162.740 |
EBITDA (p.s.) |
-0.511 |
P/E |
-1.29 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.10 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.77 |
P/CF |
-2.09 |
|
|
|
|
|
|
